Litigation Details for Cephalon, Inc. v. Abraxis Bioscience, LLC (Fed. Cir. 2014)
✉ Email this page to a colleague
Cephalon, Inc. v. Abraxis Bioscience, LLC (Fed. Cir. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-04-23 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | 2015-06-17 |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 6,096,331 | ||
| Link to Docket | External link to docket | ||
Details for Cephalon, Inc. v. Abraxis Bioscience, LLC (Fed. Cir. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-06-17 | 63 | claims as obvious in light of U.S. Patent Nos. 6,096,331 (“Desai”) and 5,855,913 (“Hanes”). In the…the assignee of U.S. Reissued Patent No. RE40,493 (“the ’493 patent”), titled “Porous Paclitaxel Matrices…other Acusphere patents in the same field, many credited to the inventors of the ’493 patent,” define …nanoparticles’ in the patent.”). In any event, the lexicography exception requires the patent drafter to …the District of Massachusetts with respect to a patent directed to formulations of, and methods of making | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
